B-Type Natriuretic Peptide Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression

Published on Jun 24, 2021in Frontiers in Cardiovascular Medicine3.915
· DOI :10.3389/FCVM.2021.690790
Angelo Zinellu31
Estimated H-index: 31
(University of Sassari),
Salvatore Sotgia25
Estimated H-index: 25
(University of Sassari)
+ 1 AuthorsArduino A. Mangoni40
Estimated H-index: 40
(Flinders University)
Sources
Abstract
Alterations in cardiac biomarkers have been reported in patients with coronavirus disease 2019 (COVID-19) in relation to disease severity and mortality. We conducted a systematic review and meta-analysis with meta-regression of studies reporting B-type natriuretic peptide (BNP) or N-terminal proBNP (NT-proBNP) plasma concentrations in COVID-19. We searched PubMed, Web of Science, and Scopus, between January 2020 and 2021, for studies reporting BNP/NT-proBNP concentrations, measures of COVID-19 severity, and survival status (PROSPERO registration number: CRD42021239190). Forty-four studies in 18,856 COVID-19 patients were included in the meta-analysis and meta-regression. In pooled results, BNP/NT-proBNP concentrations were significantly higher in patients with high severity or non-survivor status when compared to patients with low severity or survivor status during follow up (SMD = 1.07, 95% CI: 0.89-1.24, and p < 0.001). We observed extreme between-study heterogeneity (I 2 = 93.9%, p < 0.001). In sensitivity analysis, the magnitude and the direction of the effect size were not substantially modified after sequentially removing individual studies and re-assessing the pooled estimates, (effect size range, 0.99 - 1.10). No publication bias was observed with the Begg's (p = 0.26) and Egger's (p = 0.40) t-tests. In meta-regression analysis, the SMD was significantly and positively associated with D-dimer (t = 2.22, p = 0.03), myoglobin (t = 2.40, p = 0.04), LDH (t = 2.38, p = 0.02), and procalcitonin (t = 2.56, p = 0.01) concentrations. Therefore, higher BNP/NT-proBNP plasma concentrations were significantly associated with severe disease and mortality in COVID-19 patients.
📖 Papers frequently viewed together
3 Citations
4 Citations
15 Citations
References70
Newest
#1Gang LiH-Index: 1
#2Chen liang Zhou (WHU: Wuhan University)H-Index: 1
Last. Sha sha YouH-Index: 1
view all 9 authors...
Summary Objective To evaluate the nutritional risk and therapy in severe and critical patients with COVID-19. Methods A total of 523 patients enrolled from four hospitals in Wuhan, China. The inclusion time was from January 2, 2020 to February 15. Clinical characteristics and laboratory values were obtained from electronic medical records, nursing records, and related examinations. Results Of these patients, 211 (40.3%) were admitted to the ICU and 115 deaths (22.0%). Patients admitted to the IC...
21 CitationsSource
#1Weidong Qin (SDU: Shandong University)H-Index: 8
#2Wen-Wu Bai (SDU: Shandong University)H-Index: 7
Last. Mingxiang Zhang (MOE: Chinese Ministry of Education)H-Index: 18
view all 7 authors...
BACKGROUND: The severe acute respiratory coronavirus 2 (SARS-CoV-2) began in December 2019, and rapidly spread to other provinces in China as well as other countries. METHODS: In this study, 262 patients diagnosed of moderate to severe SARS-CoV-2 pneumonia in Wuhan, China, were analyzed. Data were compared between survivors and non-survivors. RESULTS: Of all the 262 patients, 23 (8.8%) patients died and 239 (91.2%) discharged. The median age was 63.5 years old and 46.9% patients were male. The m...
5 CitationsSource
#1Nesim Aladağ (UHSA: University of Health Sciences Antigua)H-Index: 2
#2Rukiye Derin Atabey (UHSA: University of Health Sciences Antigua)H-Index: 1
to identify the potential cardiovascular risk factors associated with mortality in hospitalised COVID-19 patients. All consecutive patients admitted to intensive care unit (ICU) of our institute fo...
11 CitationsSource
#1Zheying Tao (SJTU: Shanghai Jiao Tong University)H-Index: 2
#2Jing Xu (SJTU: Shanghai Jiao Tong University)H-Index: 9
Last. Jialin Liu (SJTU: Shanghai Jiao Tong University)H-Index: 9
view all 12 authors...
Background and objective Anaemia commonly aggravates the severity of respiratory diseases, whereas thus far, few study has elucidated the impact of anaemia on Corona Virus Disease 2019 (COVID-19). The aim of this study was to evaluate the clinical characteristics of patients with anaemia, and to further explore the relationship between anaemia and the severity of COVID-19. Methods In this single-center, retrospective, observational study, a total of 222 confirmed patients admitted to Wuhan Ninth...
26 CitationsSource
#1Warren Gavin (IU: Indiana University)H-Index: 1
#2Elliott Campbell (IU: Indiana University)H-Index: 1
Last. Areeba Kara (IU: Indiana University)H-Index: 5
view all 10 authors...
Abstract Background COVID-19 is a novel disease caused by SARS-CoV-2. Methods We conducted a retrospective evaluation of patients admitted with COVID-19 to one site in March 2020. Patients were stratified into three groups: survivors who did not receive mechanical ventilation (MV), survivors who received MV and those who received MV and died during hospitalization. Results There were 140 hospitalizations; 22 deaths (mortality rate 15.7%), 83 (59%) survived and did not receive MV, 35 (25%) receiv...
16 CitationsSource
Abstract Purpose We have previously reported an association between high red blood cell distribution width (RDW) and mortality in septic and brain infarction patients. However, no association between RDW and mortality in coronavirus disease 2019 (COVID-19) patients has been reported so far; thus, the objective of this study was to determine if that association exists. Methods Prospective and observational study carried out in 8 Intensive Care Units from 6 hospitals of Canary Islands (Spain) incl...
8 CitationsSource
Last. Núria Farré (Autonomous University of Barcelona)H-Index: 16
view all 12 authors...
Background: The prevalence and prognostic value of chronic heart failure (CHF) in the setting of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection has seldom been studied. The aim of this study was to analyze the prevalence and prognosis of CHF in this setting. Methods: This single-center study included 829 consecutive patients with SARS-CoV-2 infection from February to April 2020. Patients with a previous history of CHF were matched 1:2 for age and sex. We analyze the progn...
2 CitationsSource
#1Chanyan Huang (SYSU: Sun Yat-sen University)H-Index: 1
#2Jalal Soleimani (Mayo Clinic)H-Index: 2
Last. Amelia Barwise (Mayo Clinic)H-Index: 8
view all 8 authors...
A growing number of studies on coronavirus disease 2019 (COVID-19) are becoming available, but a synthesis of available data focusing on the critically ill population has not been conducted. We performed a scoping review to synthesize clinical characteristics, treatment, and clinical outcomes among critically ill patients with COVID-19. Between January 1, 2020, and May 15, 2020, we identified high-quality clinical studies describing critically ill patients with a sample size of greater than 20 p...
19 CitationsSource
#1Jie Yang (Sichuan University)H-Index: 2
#2Xuelian Liao (Sichuan University)H-Index: 9
Last. Yan Kang (Sichuan University)H-Index: 18
view all 10 authors...
Purpose The coronavirus disease 19 (COVID-19) has become a global health event Cardiac biomarkers like creatine kinase isoenzyme (CK-MB), myoglobin, and high-sensitivity troponin T were usually elevated in early stages This study aimed to investigate whether the elevated cardiac biomarkers could become effective prognostic predictors for COVID-19 patients Methods The present study involved 357 COVID-19 patients The potential predictors for two study outcomes (in-hospital death and recovery statu...
5 CitationsSource
#1Bart G Pijls (LUMC: Leiden University Medical Center)H-Index: 17
#2Shahab Jolani (PHRI: Public Health Research Institute)H-Index: 8
Last. Maurice P. Zeegers (PHRI: Public Health Research Institute)H-Index: 67
view all 11 authors...
Objective We aimed to describe the associations of age and sex with the risk of COVID-19 in different severity stages ranging from infection to death. Design Systematic review and meta-analysis. Data sources PubMed and Embase through 4 May 2020. Study selection We considered cohort and case–control studies that evaluated differences in age and sex on the risk of COVID-19 infection, disease severity, intensive care unit (ICU) admission and death. Data extraction and synthesis We screened and incl...
50 CitationsSource
Cited By0
Newest